CA Patent

CA2338121A1 — Amide derivatives useful as inhibitors of the production of cytokines

Assigned to AstraZeneca AB · Expires 2000-02-17 · 26y expired

What this patent protects

The invention concerns amide derivatives of formula (I) wherein R3 is (1- 6C)alkyl or halogeno; Q1 is heteroaryl which is optionally substituted with 1, 2, 3, or 4 substituents such as hydroxy, halogeno, trifluoromethyl, (1- 6C)alkyl, (1-6C)alkoxy, hydroxy-(1-6C)alkyl, (1-6C)alko…

USPTO Abstract

The invention concerns amide derivatives of formula (I) wherein R3 is (1- 6C)alkyl or halogeno; Q1 is heteroaryl which is optionally substituted with 1, 2, 3, or 4 substituents such as hydroxy, halogeno, trifluoromethyl, (1- 6C)alkyl, (1-6C)alkoxy, hydroxy-(1-6C)alkyl, (1-6C)alkoxy-(1-6C)alkyl, hydro xy- (2-6C)alkoxy, amino-(2-6C)alkylamino, N-(1-6C)alkyl-(1-6C)alkylamino- (2- 6C)alkylamino, aryl, heteroaryl and heterocyclyl; p is 0-2 and R2 is a substituent such as hydroxy and halogeno; q is 0-4; and Q2 includes optional ly substituted aryl, cycloalkyl, heteroaryl and heterocyclyl; or pharmaceutical ly- acceptable salts or in vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in th e treatment of diseases or medical conditions mediated by cytokines.

Drugs covered by this patent

Patent Metadata

Patent number
CA2338121A1
Jurisdiction
CA
Classification
Expires
2000-02-17
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.